Compare LACTOSE INDIA with - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

LACTOSE INDIA vs SOLARA ACTIVE PHARMA SCIENCES - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    LACTOSE INDIA SOLARA ACTIVE PHARMA SCIENCES LACTOSE INDIA/
SOLARA ACTIVE PHARMA SCIENCES
 
P/E (TTM) x -84.6 22.6 - View Chart
P/BV x 1.3 2.9 45.2% View Chart
Dividend Yield % 0.0 0.6 -  

Financials

 LACTOSE INDIA   SOLARA ACTIVE PHARMA SCIENCES
EQUITY SHARE DATA
    LACTOSE INDIA
Mar-21
SOLARA ACTIVE PHARMA SCIENCES
Mar-21
LACTOSE INDIA/
SOLARA ACTIVE PHARMA SCIENCES
5-Yr Chart
Click to enlarge
High Rs421,625 2.6%   
Low Rs16415 3.9%   
Sales per share (Unadj.) Rs30.6450.0 6.8%  
Earnings per share (Unadj.) Rs-2.261.6 -3.5%  
Cash flow per share (Unadj.) Rs1.691.8 1.8%  
Dividends per share (Unadj.) Rs07.00 0.0%  
Avg Dividend yield %00.7 0.0%  
Book value per share (Unadj.) Rs30.1441.1 6.8%  
Shares outstanding (eoy) m11.4435.93 31.8%   
Bonus / Rights / Conversions ---  
Price / Sales ratio x0.92.3 41.7%   
Avg P/E ratio x-13.316.6 -80.5%  
P/CF ratio (eoy) x17.611.1 158.1%  
Price / Book Value ratio x1.02.3 41.4%  
Dividend payout %011.4 0.0%   
Avg Mkt Cap Rs m33036,648 0.9%   
No. of employees `000NANA-   
Total wages/salary Rs m1062,294 4.6%   
Avg. sales/employee Rs ThNMNM-  
Avg. wages/employee Rs ThNMNM-  
Avg. net profit/employee Rs ThNMNM-  
INCOME DATA
Net Sales Rs m35016,169 2.2%  
Other income Rs m3288 1.1%   
Total revenues Rs m35316,457 2.1%   
Gross profit Rs m623,859 1.6%  
Depreciation Rs m441,087 4.0%   
Interest Rs m54845 6.4%   
Profit before tax Rs m-332,215 -1.5%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m-82 -528.7%   
Profit after tax Rs m-252,214 -1.1%  
Gross profit margin %17.823.9 74.6%  
Effective tax rate %24.20.1 35,805.8%   
Net profit margin %-7.113.7 -51.8%  
BALANCE SHEET DATA
Current assets Rs m19710,576 1.9%   
Current liabilities Rs m1167,888 1.5%   
Net working cap to sales %23.116.6 138.9%  
Current ratio x1.71.3 126.4%  
Inventory Days Days5914 430.4%  
Debtors Days Days67111 6,144.2%  
Net fixed assets Rs m68615,303 4.5%   
Share capital Rs m114359 31.8%   
"Free" reserves Rs m23015,488 1.5%   
Net worth Rs m34515,847 2.2%   
Long term debt Rs m3931,548 25.4%   
Total assets Rs m88325,880 3.4%  
Interest coverage x0.43.6 11.0%   
Debt to equity ratio x1.10.1 1,165.4%  
Sales to assets ratio x0.40.6 63.3%   
Return on assets %3.411.8 28.5%  
Return on equity %-7.214.0 -51.4%  
Return on capital %3.017.6 16.8%  
Exports to sales %00-   
Imports to sales %7.40-   
Exports (fob) Rs mNANA-   
Imports (cif) Rs m26NA-   
Fx inflow Rs m259,148 0.3%   
Fx outflow Rs m276,688 0.4%   
Net fx Rs m-22,460 -0.1%   
CASH FLOW
From Operations Rs m221,555 1.4%  
From Investments Rs m-62-1,063 5.8%  
From Financial Activity Rs m45925 4.9%  
Net Cashflow Rs m51,417 0.4%  

Share Holding

Indian Promoters % 49.1 41.1 119.6%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 0.7 23.3 2.9%  
FIIs % 0.0 17.3 -  
ADR/GDR % 0.0 0.0 -  
Free float % 50.9 58.9 86.3%  
Shareholders   15,737 65,449 24.0%  
Pledged promoter(s) holding % 47.2 13.6 348.0%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare LACTOSE INDIA With:   AURO LAB.  AAYUSH FOOD & HERBS   TYCHE INDUSTRIES  CADILA HEALTHCARE  ADVIK LABORS  



Today's Market

India's Fiscal Deficit, Anand Rathi Wealth IPO, and Buzzing Stocks Today(Pre-Open)

Indian share markets ended on a negative note yesterday. Benchmark indices edged lower as global cues turned bearish after US pharma.

Related Views on News

SOLARA ACTIVE PHARMA SCIENCES 2020-21 Annual Report Analysis (Annual Result Update)

Oct 22, 2021 | Updated on Oct 22, 2021

Here's an analysis of the annual report of SOLARA ACTIVE PHARMA SCIENCES for 2020-21. It includes a full income statement, balance sheet and cash flow analysis of SOLARA ACTIVE PHARMA SCIENCES. Also includes updates on the valuation of SOLARA ACTIVE PHARMA SCIENCES.

SOLARA ACTIVE PHARMA SCIENCES Announces Quarterly Results (1QFY22); Net Profit Up 18.5% (Quarterly Result Update)

Aug 5, 2021 | Updated on Aug 5, 2021

For the quarter ended June 2021, SOLARA ACTIVE PHARMA SCIENCES has posted a net profit of Rs 501 m (up 18.5% YoY). Sales on the other hand came in at Rs 4 bn (up 16.4% YoY). Read on for a complete analysis of SOLARA ACTIVE PHARMA SCIENCES's quarterly results.

This Stock Just Made a Historical Debut on the Exchanges (Views On News)

Nov 15, 2021

Shares of the company listed at premium of 253% from its IPO price, the highest ever.

3 Indian Pharma Companies that are Investing Big Time for the Future (Views On News)

Nov 9, 2021

In 2021, R&D of pharma companies roared to life in a never-before-seen way.

Demerger of Financial & Pharma Businesses puts Piramal Enterprises in Limelight (Views On News)

Oct 8, 2021

The company's shareholders will be issued 4 shares in the demerged entity for every 1 held in Piramal Enterprises.

More Views on News

Most Popular

Infosys vs TCS: Which is Better?(Views On News)

Nov 26, 2021

In the post pandemic era, the top two IT companies in India are fighting to capture the growing demand for IT.

This Multibagger Stock Zooms 20% After Dolly Khanna Buys Stake(Views On News)

Nov 24, 2021

Shares of this edible oil company zoomed over 50% in three days after ace investor bought around 1% stake.

6 Popular Stocks that Turned into Penny Stocks(Views On News)

Nov 27, 2021

A look at popular stocks that crashed big time and never recovered, i.e. which went from 'Multibaggers to Multibeggers'.

How to Find Your Next 10-Bagger in this Market(Profit Hunter)

Nov 19, 2021

The #1 make or break factor in your portfolio you shouldn't ignore.

MobiKwik IPO Opens for Subscription Soon. Key Things to Know Before Subscribing.(Views On News)

Nov 20, 2021

The Rs 19 bn issue is set to hit the market soon.

More

Become A Smarter Investor
In Just 5 Minutes

Multibagger Stock Guide 2022
Get our special report Multibagger Stocks Guide (2022 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

LACTOSE INDIA SHARE PRICE


Nov 30, 2021 (Close)

TRACK LACTOSE INDIA

  • Track your investment in LACTOSE INDIA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

LACTOSE INDIA - ZOTA HEALTH CARE COMPARISON

COMPARE LACTOSE INDIA WITH

MARKET STATS